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A B S T R A C T
The recycling and recovery of organic matter and nutrients from sewage sludge for application in
agricultural soils is gaining interest, while the presence of pharmaceutically active compounds (PhACs) in
this matrix may have a great impact on the environment and human health. The aim of this review paper
is to outline recent research on the occurrence of PhACs and their metabolites in sewage treatment lines.
A total of 32 classes of therapeutic groups including 180 PhACs and 45 metabolites have been included. In
a first part, a summary of the analytical methods with a critical overview of the extraction and
determination techniques, quality control issues and methodological challenges for their determination
is included. Subsequently, the study gives a snapshot of the concentration levels and distribution patterns
found in primary, secondary, digested (aerobically and anaerobically), dehydrated and composted sludge.
Data have been systematically summarized and categorized according to matrix type, treatment
processes available for PhAC degradation in sludge, and geographical areas. Our literature review showed
that antimicrobials, antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), antidepressants and
antidiabetics were the most abundant PhACs found in sludge matrices.Overall, attenuation of PhACs
concentrations occurs during sludge stabilization, in particular during anaerobic digestion and
composting. PhAC sorption onto sludge is strongly affected by the physicochemical properties, the
sludge matrix and the operating and environmental conditions. Lastly, the paper discusses the impact of
PhACs on sludge-amended agricultural land. The potential ecotoxicological risk associated with the
presence of PhACs in amended soil is medium-low for most PhACs. The most critical compounds found in
sludge-amended soil are ciprofloxacin,17α-ethinylestradiol,17β-estradiol, and triclocarban and triclosan.
© 2021 Elsevier B.V. All rights reserved.
1. Introduction
Pharmaceutically active compounds (PhACs) are anthropogenic
contaminants that are continuously released into the environment
and that may have a great impact on ecosystems and human
health. Before their discharge in the environment, PhAC-rich
influents are processed in wastewater treatments plants (WWTPs).
The incomplete removal or degradation of PhACs in WWTPs results
in the presence of these contaminants in wastewater effluents
(ranging from ng/L to mg/L) and in biosolids (mg/kg to mg/kg) [1–
3]. Based on mass balance studies, between 55 % and 100 % of
norfloxacin, ciprofloxacin, ofloxacin and lomefloxacin (quinolone
antibiotics), hydrochlorotiazide (antihypertensive), fenofibrate (a
lipid-regulating agent), and propranolol (beta blocker) are
removed in WWTPs being sorbed onto sewage sludge [3–9]. Their
removal by activated sludge processes involves the formation of
Abbrevations: AeD, aerobic digestion; AnD, anaerobic digestion; APPL, dry-
sludge application rate; d-SPE, dispersive solid phase extraction; d.m., dry matter;
DEPTH, mixing depth of soil; EC, effect concentration; ESI, electrospray ionization
source; GC/MS, gas chromatography with mass spectrometry detector; HF-LPME,
hollow-fiber liquid phase microextraction; HILIC, hydrophilic interaction liquid
chromatography; Kd, distribution or partition coefficients; LC–MS/MS, liquid
chromatography with tandem mass spectrometry; LC, lethal concentration; MAE,
Microwave assisted extraction; MEC, measured environmental concentration;
MSPD, matrix solid phase extraction; NOEC, no observed effect concentration;
NSAIDs, non-steroidal anti-inflammatory drugs; PEC, predicted environmental
concentration; PhACs, pharmaceutically active compounds; PHWE, pressurized hot
water extraction; PLE, pressurized liquid extraction; PNEC, predicted no-effect
concentration; QA/QC, quality assurance/quality control; QqQ, triple quadrupole;
QuEChERS, Quick, Easy, Cheap, Effective, Rugged and Safe; RHO, bulk density of wet
soil; RQ, risk quotient; SPE, solid phase extraction; SPME, solid phase microextrac-
tion; SRT, sludge retention time; TOC, total organic carbon; TOF, time of flight; USE,
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ewage sludge generated, these compounds are also becoming a
ajor global environmental problem [3,10].
In 2021, approximately 15 million tons of sludge (dry matter d.
.) will be produced in the European Union (EU) 28 [11,12]. Around
0 % of this sludge will be used as a source of organic matter and
utrients for agricultural purposes [13–15], but with large %
ariations in its application between the Member States of the EU
no application in countries like Malta, the Netherlands, Slovenia
r Slovakia, and more than 50 % in Denmark, Spain, Ireland, and
rance) [11–14]. Land application of treated sewage sludge has also
een widely used to reduce the sludge disposal cost component of
ewage treatment in developed countries like the USA, Canada,
ustralia, New Zealand but particularly in developing countries
14].
EU Directive 86/278/EEC on the protection of the environment,
nd in particular of the soil, when sewage sludge is used in
griculture, was set to promote the application of sewage sludge to
gricultural soils and to ensure its use does not harm the
nvironment, humans or animals [16]. This Directive no longer
ts the current needs and is currently under revision for its
pgrade [14,17,18]. In 2010, the 3rd draft of the revision document
n sludge proposed stricter limits for heavy metals and the
ossibility of analysing halogenated organic compounds in sludge
19]. In spite of everything, there are no regulations regarding the
nalysis of new emerging contaminants in sewage sludge [20]. The
resence of PhACs in sewage sludge is becoming a matter of special
oncern because several studies have showed low-effect concen-
rations, crop transfer and multi-resistant pathogens [21–26].
Although PhAC concentrations in treated sludge are often
elated to their concentrations in wastewater influents [23,27,28],
he physicochemical characteristics of the different PhACs can also
nfluence their concentration [29], sludge matrix [28,30], and the
perational parameters used for sewage treatment [31,32]. This
aper reveals the necessity of introducing monitoring programs in
ewage sludge with the aim of evaluating and reducing potential
ources of PhACs that enter the environment through the common
ractice of using this biosolid as a fertilizer in agriculture. The
eview of the literature published in the last ten years provided us
ith data on the concentration of PhACs and their main
etabolites found along different sludge treatment processes.
he potential routes for their removal under aerobic and anaerobic
onditions are discussed. Lastly, the paper examines the impact of
hAC-contaminated sewage sludge on land and the environmental
isk assesment.
. Analytical methods, quality control and challenges
Sewage sludge is a challenging matrix due to its complex nature
nd heterogeneous composition. This fact, along with the low
oncentrations of PhACs found in this matrix, makes the sampling,
ample preparation and analytical determination critical steps that
eed to be carefully examined. Regarding the sampling procedure,
 significant challenge in the PhAC analysis is to ensure
epresentativeness, which is probably the main source of errors
hat often receives little attention. Adequate representativeness
equires the collection of a number of random sub-samples which
an then be pooled to obtain a representative composite. Martín
t al. [33] collected 2 L of primary and secondary sludge and 1 kg of
naerobically digested dehydrated sludge and compost. Their
solvent extraction (USE) is still widely applied for PhAC extraction
in sewage sludge (more than a half of the publications) [34,37,38].
However, USE requires a manual manipulation of the extracts, long
times as well as large consumption of reagents. In the last decade, a
trend towards more environmentally friendy processes with lower
cost, and automatization and miniaturization techniques [pres-
surized liquid extraction (PLE), matrix solid phase extraction
(MSPD), Quick, Easy, Cheap, Effective, Rugged and Safe (QuECh-
ERS), pressurized hot water extraction (PHWE), and others] have
emerged [34,39–42]. Among these novel techniques, PLE with
organic solvents or their mixture with an aqueous solvent is the
most commonly applied extraction technique.
In most cases, the extraction procedure is not selective and a
clean-up step is necessary. For sludge samples, solid phase
extraction (SPE), with C18 or Oasis HLB sorbents, or dispersive-
SPE (d-SPE), C18 and PSA sorbents, are commonly applied for
clean-up [33,37,40]. However, compared to the extraction alone,
this step significantly increases the analysis time and involves
additional sample manipulation. In this regard, Rossini et al. [43]
developed a combined approach of QuEChERS extraction with on-
line SPE-liquid chromatography to tandem mass spectrometry
(LC–MS/MS) in order to eliminate the d-SPE step of QuEChERS for
the determination of non-steroidal anti-inflammatory drugs
(NSAIDs) and their metabolites in sludge. Saleh et al. [42] applied
for clean-up the novel hollow-fiber liquid phase microextraction
(HF-LPME), after PHWE extraction, for the analysis of NSAIDs in
sludge samples. When PLE or MSPD are chosen as extraction
tecniques, the clean-up can be performed together with the
extraction therefore reducing analysis time and tedious work
[40,41]. Future efforts should be done to develop on-line coupling,
automatic or semi-automatic protocols.
Given the wide range of psychochemical properties (including
many polar and non-volatile compounds), the most suitable
technique for the detection of PhACs and their metabolites is LC–
MS/MS using reverse phase. In the last years, the use of hydrophilic
interaction liquid chromatography (HILIC), which involves the use
of a hydrophilic stationary phase and an aqueous-polar/organic
solvent mobile phase, is gaining interest for the analysis of polar
compounds, especially PhAC metabolites [34–36,41]. The triple
quadrupole (QqQ) is widely considered as the most sensitive and
selective analyzer for PhAC determination in sewage sludge
samples. Nevertheless, recent advances in LC–MS have shown
that time of flight (TOF) [44] or orbitrap [45] analyzers are a very
suitable alternative to QqQ, allowing the screening of targeted and
untargeted analytes [34–36].
Table 1 [33,37–44,46–51] shows a summary of multi-residue
methods described in the literature for the determination of PhACs
and their metabolites in different types of sludge samples. An
important limitation of the reported studies is that most of them
have been developed and validated for only one or maybe two
types of sludge. However, to achieve a full assessment of PhAC
distribution in WWTPs, measurements of PhAC concentrations
need to be done in the different types of sludge from all the
treatment stages, because some factors such as sample amount,
reconstitution volumes and matrix effects could differ between
sludge types. In addition, very few methods focus on the
determination of PhAC metabolites, and those found are focused
on a single PhAC [44,51], or on PhACs from the same therapeutic
group [43,47]. Recently, Malvar et al. [40] have compared USE, PLE
and QuEChERS for the determination of PhAC metabolites fromnalytical method involved sample homogenization, freeze drying
nd sieving and they used 1.0 g of primary or secondary sludge,
.5 g of digested sludge or 2.0 g of compost aliquots for sample
rotocol.
Generally, sample preparation involves extraction, clean-up
nd pre-concentration steps [34–36]. The conventional ultrasonic2
different therapeutic groups (NSAIDs, antibiotics, antiepileptic
drugs and central nervous system stimulants) in digested sludge
and found that PLE was the most suitable extraction method
because of its higher accuracy and sensitivity as well as the
automatisation capacity for simultaneous sample extraction and
clean-up.
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assurance/quality control (QA/QC) protocol must be established.
This protocol involves the use of control spiked samples, solvent
injections, and procedural blanks into each analytical batch. Due to
the lack of certified reference materials, in-house reference
materials (prepared by spiking real samples) are used to check
signal when compared with standards in solvent. Sludge matrix
has a high content of organic components, which could increase
the viscosity of the sample and the superficial tension of the
droplets generated in the ESI source, which may decrease the
evaporation efficiency of the target analytes. The presence of
matrix effect in MS analysis can be evaluated by comparing the
Table 1
Analytical methods described in the literature for the determination of PhACs and their metabolites in different types of sludge samples.














NSAIDs and metabolites, antibiotics and
metabolites, antiepileptic drugs and




2 PLE – LC-MS/MS 59100 0.13.5 [40]
USE d-SPE (PSA and
C18)
2288 0.25.3
QuEChERS d-SPE (PSA and
C18)
2578 0.211
NSAIDs, antibiotics, antiepileptic, nervous
stimulant, analgesics
Sludge 2 USE SPE (C18) GC/MS 5089 0.11.7 [37]
Soil 2 46106 0.11.4
NSAIDs and lipd regulators Mixed
sludge
0.8 MAE SPME GC/MS 3070 <20 [39]
NSAIDs and metabolites, anesthetic drugs,
antiepileptic drugs, β- blockers, lipid
regulators, antidiabetics, antipsychotics,
antidepressants
Sludge 2 MSPD – HILIC-MS/MS 45122 1.251250 [41]
NSAIDs, antibiotics, antiepileptic, lipid
regulators, antidepressants
Sludge 1 USE QuEChERS and
SPE (Oasis HLB)
LC/MS-MS 60189 9.11230 [38]
Soil 5 60135 2.165.3
NSAIDs and metabolites Sludge 1 QuEChERS SPE (on-line,
Strata X)






0.1 USE – LC-MS/MS 50110 0.910 [46]
Antibiotics and metabolites Sludge 2 PLE SPE (Oasis HLB) LC/MS-MS 0.032.23 [47]
Soil 5 60130 0.010.55
NSAIDs, Hormones, antibiotics,
antidepressants, antipsychotics,
antibacterials, antihistamines, proton pump
inhibitors, anticoagulants, radiocontrast
agents, anthelminthics, lipid regulators,




2 QuEChERS d-SPE (PSA) LC/ToF-MS 33135 1.02500.0 [44]
NSAIDs Digested
sludge
0.5 PHWE HLPME LC-MS/MS 2330 0.43.7 [42]
NSAIDs, antibiotics, antiepileptic, β- blocker,
nervous stimulant, estrogens, lipid regulators
Primary
sludge







Compost 2 55106 0.1344.7
Sediment 2 42103 0.3650.5











NSAIDs, antibiotics, antiepileptics, β- blocker,
nervous stimulant, lipid regulators
Digested
sludge
1 PLE – LC/MS 45120 2350 0.8120 [49]
Soil 2.7 50110
NSAIDs, antibiotics, β-blocker, nervous
stimulants, lipid regulators
Sludge 5 PLE – LC/MS 72109 1432* [50]
Antiepileptic drugs and metabolites Untreated
sludge




GC/MS: gas chromatography with mass spectrometry detector; HILIC: hydrophilic interaction liquid chromatography; HLPME: Hollow fiber liquid phase microextraction; LC–
MS: liquid chromatography with mass spectrometry detector; LC-ToF: Liquid chromatography–time-of-flight-mass spectrometry; MAE: Microwave assisted extraction;
PHWE:Pressurized hot water extraction; PLE: Pressurized liquid extraction; SPE: Solid Phase Extraction; SPME: Solid Phase Microextraction; USE: Ultrasonication solvent
extraction;*: Method quantification limits.for accuracy during validation and QA/QC. One of the greatest
drawbacks of PhAC analysis in sludge samples by LC–MS/MS when
using the electrospray ionization source (ESI) is the perturbation of
the signal by co-extracted substances coming from sludge matrix
that may cause ion suppression or improvement of the analyte3
response obtained for standards directly injected in the mobile
phase with the response for the same amount of standard added to
the already extracted sample [44]. In practice, different ways can
be used to reduce matrix effects: 1) the improvement of the clean-
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ample dilution (decreases the amount of organic load entering the
nalyzer and improves the signal, but it can reduce the sensitivity);
nd 3) quantification using matrix-matched calibration curves as
ell as the use of isotopically labeled internal standards. The latter
s the most common procedure, but it is costly and usually has
imited commercial availability [40,47].
. Occurrence of PhACs during sludge treatment
Typically, four types of sawage sludge [primary, secondary,
erobically or anaerobically digested, and dehydrated] can be
dentified in a WWTP (Table S1). A summary and comparison of the
oncentration levels of 180 PhACs and 45 metabolites detected in
ewage sludge worlwide is shown in Tables S2 and S3, respectively.
oncentrations vary substantially depending on the chemical, the
sage, sludge matrix or geographical area, ranging from mg/kg to
ew mg/kg [27,51–54]. More than 70 % of published data
etermined concentrations often measured in the final product
3.1. Untreated sludge: Primary and secondary sludge
Fig. 1 shows the concentration levels of PhACs and the
metabolites more frequently detected in primary and secondary
sludge as box-and-whisker plots. The five pharmaceutical classes
most frequently measured and at higher concentrations were
antimicrobials > antibiotics > NSAIDs > antidepressants > antidia-
betics. The highest concentrations were found for the antimicro-
bial triclocarban (mean of 21,000 ng/g dm in primary sludge and
13,000 ng/g dm in secondary sludge). Fluoroquinolones were
detected in a wide concentration range, reaching values of up to
12,858 ng/g dm for ciprofloxacin and 6712 ng/g dm for ofloxacine
in France [61]. Together with fluoroquinolones, the presence of
macrolide antibiotics in treated sludge represents an issue of
concern related to the development of antibiotic resistance. Park
et al. [65] found clarithromycin concentrations of 100500 ng/g
dm in a WWTP in Korea, while Mailler et al. [61] and Muriuki et al.
[66] found higher concentrations for azythromicyn and sulfame-
thozaxole, up to 350 and 300 ng/g dm, in France and Kenia,
ig. 1. Box-and-whisker plots on concentrations of PhACs (A) and metabolites (B) in primary (P, left box) and secondary (S, right box) sludge. (Antiep.: Antiepileptic drugs;
ntidepre.: Antidepressants; Antidiab.: Antidiabetic drugs: Antilipem.: Antilipemic drugs; Stim.: Stimulants; Anal.: Analgesics; Antianx.: Antianxiety drugs; Gastr.:
astrointestinal agent; Antihyp.: Antihypertensive; Hist.: Antihistamines; Plat.: Antiplatelet agents).f the sewage sludge treatment (digested, dehydrated or com-
osted sludge) [23,55–57] or concentrations obtained from
aboratory studies or from pilot-scale WWTPs [58–60]. Only few
tudies have reported on the distribution of PhACs during the
ludge stabilization treatment [53,61–63], and studies on metab-
lite distribution are even more lacking [52,64].4
respectively. Anti-inflammatory drugs such as diclofenac, ibupro-
fen and acetylsalicylic acid were also present in concentrations of
1228, 1332 and 1000 ng/g dm, respectively, in primary sludge, and
78, 611 and 900 ng/g dm in secondary sludge. The anticonvulsant
carbamazepine is one of the most frequently studied and detected
PhACs in sludge samples (Table S2), known for its persistence. Its
C. Mejías, J. Martín, J.L. Santos et al. Trends in Environmental Analytical Chemistry 30 (2021) e00125mean concentration ranged between 0.9 ng/g dm in China [67] to
256 ng/g dm in Spain [25]. Other frequently measured and
quantified pharmaceutical groups include beta-blockers (propran-
olol and atenolol), antidepressants (citalopram and venlafaxine),
stimulants (caffeine) and antilipemic drugs (gemfibrozil and
bezafibrate), which can be attributed to their high consumption,
although overall they were detected at lower levels.
High concentrations in primary sludge can be attributed to high
concentrations (i.e. caffeine, ibuprofen or citalopram) in incoming
or influent wastewater, or high partitioning to sludge because of
their high hydrophobicity (i.e. triclosan or triclocarban). Depend-
ing on sewage sludge properties, the percentage of PhAC
adsorption may vary [68]. Sorption occurs mostly through
hydrophobic interactions between PhACs and the organic matter
in sludge [31,69]. Hence, PhACs of hydrophobic nature such as
triclocarban or triclosan (Log Kow values of 3.5–4.8) tend to heavily
partition onto the particulate phase. However, not all PhACs
detected in sludge are lipophilic compounds, many of them have
polar functional groups (-NH2 or COOH groups) and can adsorb
onto organic matter or minerals via electrostatic interactions
regardless of their lipophilicity. In this regard, high concentrations
of hydrophilic chemicals such as norfloxacin (log Kow 1.03, up to
6049 ng/g dm [61]), acetaminophen (log Kow 0.46, up to 480 ng/g
dm [70]) or atenolol (log Kow 0.16–1.95, up to 95 ng/g dm [65])
have been detected in primary and secondary sludge samples. At
pH = 2.9 (isoelectric point [pI]) sludge surface will be negatively-
charged in normal environmental conditions. Therefore, those
PhACs that are normally neutral or positively-charged at pH 7
(tetracyclines, fluoroquinolones, beta-blockers and macrolides)
are highly sorbed onto primary and secondary sludge [7,23,31,71–
75]. In addition to electrostatic interactions, the formation of
complexes can occur between PhACs and their metabolites, such as
tetracyclines and metal cations (i.e. Mg2+, Ca2+, and Cu2+) present
in sludge, which will also have an impact on their concentration
[72–76].
There are others factors involved in the sorption of PhACs onto
sludge [77] like the carbon content of sludge [31]. In this regard, Li
et al. [69] found that sorption of antibiotics onto secondary sludge
is positively correlated with the total organic carbon (TOC) content
of sludges (7–45 % TOC). Zhang et al. [78] also found an increased
sorption of 17α-ethinylestradiol with higher TOC contents (44–47
% TOC). However, other studies have not find these correlations
[79,80].
Considering the large amounts of some PhACs that are
metabolized in WWTPs, metabolites are also abundantly found
in sludge samples (Fig. 1B). However, metabolites have been less
studied than their parent compounds although sometimes they
have been detected at higher concentrations. Salicylic acid and
norsetraline are the compunds found at the highest concentrations
in sewage sluge, up to 931 and 541 ng/g dm, respectively, in
primary sludge (individual data in Table S3), despite their
hydrophilicity (log Kow < 3.0) and the fact that they exist as
anions under environmental pH. Some authors have explained this
is a consequence of complex formation between the salycilic acid
phenolic group (OH) and Fe3+ present in the particulate matter
of sludge [81]. Recently, Malvar et al. [52] reported that the
detected concentrations of ibuprofen, carbamazepine and diclo-
fenac metabolites were related to their metabolic ratios. They also
found similar concentrations of metabolites in both primary and
secondary sludge, but found significantly higher concentrations of
of conjugates [13,14,76]. In this regard, Brown et al. [8] found a
similar sorptive capacity of thyroxine and its metabolite glucuro-
nide thyroxine, although the latter has a lower logKOW (2.65 vs
4.15). Both compounds were detected at higher concentrations in
secondary sludge than in primary sludge.
The concentrations reported for some compounds such as
fluoroquinolones, diclofenac, ibuprofen, sertraline, gemfibrozil and
caffeine significantly differ between studies, even up to three
orders of magnitude (Fig. 1). These variations may be explained by
the different prescribing habits related to human health con-
ditions, sampling regions or climate conditions [23,27,83].
Moreover, some results were obtained by sampling only one or
few WWTPs, which may not reflect the actual pollution status.
Variations can be found not only between countries but also within
them. For example, Chen et al. [23] found that PhAC concentrations
in sludge from East China differed significantly from sludge from
North or West China. Overall, studies on PhAC presence in sludge
are mostly conducted in European countries, followed by the U.S.
Canada and China. More investigations in the African continent are
needed and expected to emerge soon (Fig. S1 in supplementary
materials). Recently,Muriuki et al. [66] quantified antibiotics and
antiretroviral agents in primary sludge using different technolo-
gies at concentration levels ranging from < limit of quantification
(LOQ) to 31,555 ng/g dm.
3.2. Stabilization: anaerobically or aerobically digested sludge
Sludge is generally stabilized using anaerobic (AnD) or aerobic
(AeD) digestion, which may play an important role on sludge
contamination [11,58,84]. Each digestion process offers biodegra-
dation pathways due to the distinct microbial communities. The
concentrations of PhACs and metabolites in anaerobically or
aerobically digested sludges are shown in Fig. 2 A and B,
respectively, as box-and-whisker plots. The most studied and
detected pharmaceutical classes in digested sludge correspond to
those found in primary and secondary sludges: antibiotics, NSAIDs,
antiepileptic and antidepressant drugs. PhACs detected at higher
concentrations in digested sludge include triclocarban (up to
21,000 ng/g dm), ciprofloxacin (12,858 ng/g dm), ofloxacin
(6712 ng/g dm), norfloxacin (6049 ng/g dm), diclofenac
(7020 ng/g dm), ibuprofen (4105 ng/g dm), caffeine (2828 ng/g
dm) and gemfibrozil (1562 ng/g dm). Studies involving the
assessment and distribution of compounds during the sludge
stabilization treatment show that attenuation occurs in their
concentrations during AnD and AeD.
In most developed countries, sludge undergoes AnD stabiliza-
tion (about 70 % of sewage sludge), therefore, comparison of PhAC
concentrations in anaerobically or aerobically digested sludge is
not normaly done [84]. Ivanova et al. [11] found that PhAC
concentration patterns between AnD and AeD was significantly
different. Telmisartan, sertraline, azithromycin, irbesartan were
more abundantly detected in aerobically digestedsludge. In
contrast, THCCOOH, fexofenadine, citalopram and N-desmethyl-
citalopram concentrations were higher in anaerobically digested
sludge. The results reported by Alenzy et al. [85] and Joss et al. [86]
suggest that anaerobic microorganisms increase the removal of
clarithromycin, erythromycin and estrogens, versus aerobic
bacteria. In contrast, Ying and Kookana [87] detected triclosan
at significantly lower concentrations in aerobically digested
(220 mg/kg) than in anerobically digested sludge (5580 mg/kg).10-OH-carbamazepine, 2-OH-ibuprofen and carboxy ibuprofen in
primary sludge than in secondary sludge, probably due to
biodegradation of these compounds during secondary treatment
[82]. For some compounds, the metabolite concentrations is higher
in secondary sludge than in primary sludge, probably due to the
presence of organic matter in sludge and to the higher hydrolysis5
In laboratory-scale reactors dicloflenac, naproxen and roxithro-
mycin were recalcitrant under anoxic conditions, but exhibited
moderate-high removal (e.g. 14.9–60 %) under aerobic conditions
[31,88,89].
Recently, several authors have reported enhanced PhAC
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diclofenac, 2OH-ibuprofen) to high (oxazepam, propranolol,
floxacin) removal using an hybrid process involving a thermo-
hilic aerobic reactor combined with mesophilic AnD, while
emoval rates higher than 90 % were found for caffeine and
ulfamethoxazole regardless the process. Ahmad and Eskicioglu
59] observed that the sequential anaerobic/aerobic/anoxic diges-
ion configurations improved PhAC removal (from 10 to 50 %) by
ither reducing their accumulation or enhancing their removal.
imilar results were reported by Abbot and Eskicioglu[58] who
ound removal rates for triclosan and related compounds in
igested sludge of up to 80 and 97 % using temperature cycling
erobic/anoxic digesters and sequential conventional mesophilic
nD + aerobic/anoxic processes, respectively, versus 40 % removal
sing single AnD. Longer sludge retention times (SRTs) also
mproved the removal of triclosan and organic matter across each
ype of digestion examined. Zhou et al. [91] reported that AnD
ntegrated with mixed enzymolyses together with an ultrasonic
rradiation pre-treatment and AnD integrated with mixed enzy-
olyses together with mechanical rotary disc post-treatment
anaerobic reactors. For diclofenac and diazepam, removal was
associated with the temperature: 60 % for both compounds under
mesophilic conditions, and 38 % for diclofenac and 73 % for
diazepam under thermophilic conditions. In this study, the SRT (15
or 30 days) did not seem to influence PhAC removal. In another
experiment in batch conditions, Heidler et al. [93] observed that
triclocarban was not degraded during AnD after 19 days of
incubation and, as a consequence, the treated sludge showed a
higher concentration of this compound. Carbamazepine and
diclofenac seem also recalcitrant during experiments with AnD
[32,77]. While other compounds were time-dependent, bisoprol
removal was 14 % after 161 days and naproxen removal 100 % after
14 days. Lastly, 6-O-Desmethylnaproxen was detected in sludge
during anaerobic biodegradation of its parent compound [28,94].
Researchers have also suggested that the inhibition of
methanogen bacteria by PhACs is correlated with their affinity
to sorb onto anaerobic sludge and with their concentration levels
[28,95–99]. Li et al. [94 found that a small addition of
fluoroquinolones (2 mg/L) results in a slight increase of methane
production, but a high addition (100 mg/L) resulted in no
ig. 2. Box-and-whisker plots on concentrations of PhACs (A) and metabolites (B) in aerobically digested sludge (left box) and anaerobically digested sludge (right box).
Antiepileptic drugs; Antidepre.: Antidepressants; Antidiab.: Antidiabetic drugs: Antilipem.: Antilipemic drugs; Stim.: Stimulants; Anal.: Analgesics; Anx.: Antianxiety;
astr.: Gastrointestinal agent; Gastr.: Gastrointestinal agent; Diur.: Diuretic drugs; Anest.: Anesthetics).ight improve PhAC removal.
In addition to PhAC properties and sludge characteristics,
WTP operation paratemeters also seem to be involved in
ompound removal [28,77]. Carballa et al. [92] reported removal
 80 % for naproxen, sulfamethoxazole, and roxithromycin at both
esophilic (37 C) and thermophilic (55 C) temperatures in6
improvement or even in an 8% reduction of methane production.
These results are consistent with the pioneering results obtained
by Sanz et al. [96] that showed that erythromycin concentrations of
up to 250 mg/L did not inhibit biogas production, while some
antibiotics such as tylosine, doxycline, and neomycine partially
inhibit biogas formation by interfering with the activity of
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study Fountoulakis et al. [97] observed a 50 % inhibition of
methanogenesis at concentrations up to 400 mg/L of sulfameth-
oxazole and clofibric acid and 30 mg/L of propranolol. Recently,
Silva et al. [100] observed different effects of PhACs (ciproflox-
acin>17α-ethynylestradiol > diclofenac > ibuprofen) on the activi-
ty of acetogens and methanogens in anaerobic communities. None
of these PhACs affected methanogenesis at low concentrations
present in WWTP influents. A recent study by Alenzi et al. [85]
demonstrated that long-term presence of PhACs induces process
disturbances, which lead to volatile fatty acid accumulation. In
contrast, anaerobic bacteria seem to improve the removal of
clarithromycin and erythromycin over aerobic treatment.
Lastly, regarding the behaviour of metabolites during digestion
processes we have found only one study about their occurrence in
different sewage sludge stabilization treatments. This issue
requires further investigation, as some metabolites might be
present at high concentrations and contribute to toxicity. In this
regard, Malvar et al. [52] revealed a high persistence of 3-OH-
carbamazepine and 4-OH-diclofenac whereas paraxanthine, the
main metabolite of caffeine, showed a high biodegradability. The
hydroxylation and carboxylation of ibuprofen occur both under
AeD and AnD.
3.3. Final product: dried and composted sludge
The concentrations of PhACs and metabolites in digested and
dehydrated sludge and biosolid compost are shown in Table S2-S3
and summarized in Fig. 3. Comparatively, treated sludge (digested,
dehydrated and composted) is the most frequently analyzed
matrix as well as the matrix where more number of PhACs are
analyzed (68 % of selected papers vs 31 % in primary and secondary
sludge). A considerable attenuation in PhAC concentrations occurs
during the drying and maturation or composting processes,
probably because hydrosoluble PhACs present in sludge might
undergo sunlight-driven photodegradation [101] as well as
mineralization and dilution as a result of the mixing with other
products occurring during composting. Arun et al. [68] reported
two fold concentrations of fluoroquinolones in wet sludge versus
dry sludge (environment temperature 28.6 C). Similar results
have been reported by Speltini et al. [102]. A small percentage of
fluoroquinolones undergo photodegradation during the drying
process.
As with other sludge matrices, there is much variation in PhAC
concentrations and distribution between the different by-products
of sludge treatment as well as within the same country, and
therefore no clear tendency has been detected. The observed
variations can be explained by differences in population density
(rural versus urban), type of treatment process versus no
treatment, and degree of PhAC consumption [103,104]. In a study
carried out by Chen et al. [23] in dewatered sewage sludge from
China, ofloxacin was the most abundantly detected PhACs with
concentrations up to 24,760 mg/kg dm, followed by oxy-
tetracycline at 5280 mg/kg dm, norfloxacin at 5280 mg/kg dm,
and ketoprofen at 4458 mg/kg dm.
Bastos et al. [86] found that the concentration of PhACs in
treated sludge is related to the maturation time and the type of
treatment: lime sludge stabilization (7619 mg/kg dm, total
concentration) > digested sludge (2364 mg/kg dm) > composted
sludge (264 mg/kgdm). The authors observed that the longer the
maduration of organic waste, the lower PhAC concentrations.
Kim et al. [105] investigated the mineralization of tetracyclines,
sulfonamides, and macrolides during composting and found that
after 5–6 weeks in batch reactors, PhAC concentrations declined
below the relevant Korean guideline. This reduction is due to
bacterial release of hydrolytic enzymes such as cellulase, protease,
and lipase [106]. Chenxi et al. [107] showed that PhAC removal was
compound- and time-dependent and found no removal forFig. 3. Box-and-whisker plots on concentrations of PhACs (A) and metabolites (B) in dewatered sludge.
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Table 2
Concentrations of PhACs in sewage sludge-amended soils.
PhAC Measured concentration (ng/g dm) Predicted concentration (ng/g dm) Reference
Ciprofloxacin 350–400 after 8 months sludge application [114]
270–280 after 21 months sludge application [114]
450 (2.5 cm depth) [115]
542 (day 0) - 390 (day 994) [116]
<LOQ-8.7 (soil amended with composted sludge) 1.55.6 [117]
0.17 [118]
Norfloxacin 320–290 after 8 months sludge application [114]
270–300 after 21 months application [114]
350 (2.5 cm depth) [115]
50 (day 0 in a mesocosms experiment) [116]
<LOQ-9.4 (soil amended with composted sludge) 0.85.5. [117]
0.36 [118]
Ofloxacin 470 (day 0) - 267 (day 994) [116]
5.3–8.6 (soil amended with composted sludge) 5.28.0 [117]
0.23 [118]
Trimethoprim 0.642.15 (no amended experiment) [119]
n.d.0.64 [120]





20 (day 0 in a mesocosms experiment) [116]
0.28 [118]
Oxytetracycline 0.23 [121]
Doxycycline 15 (day 0 in a mesocosms experiment) [116]
0.26 [121]

















Acetylsalicylic acid 0.36 [121]
Salicylic acid 0.52 [118]
Propranolol 0.069 [118]
Metoprolol 0.12 [118]
Carbamazepine 6 (day 0 in a mesocosms experiment) [116]
<LOQ-0.2 (soil amended with composted sludge) 0.10.3 [117]






Fluoxetine 10 (day 0 in a mesocosms experiment) [116]
Venlafaxine 0.15 [118]
Miconazole 60 (day 0 in a mesocosms experiment) [116]
Diphenhydramine 40 (day 0 in a mesocosms experiment) [116]
<LOD-40 (sludge amended field) [120]
Metformin 0.35 [118]







17 beta-estrdiol 0.120.47 [25]
Estriol 0.01 [25]
Estrone 0.25–0.41 (sludge amended soils) [126]
Diethylstilbestrol <LOD-0.4 (sludge amended soils) [126]
Mestranol 0.10–0.21 (sludge amended soils) [126]
Dienestrol 0.983.3 (sludge amended soils) [126]
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anaerobic treatments. Tetracycline and doxycycline needed 77
days to be slightly removed and erythromycin and clarithromycin
were removed relatively fast. Authors also reported a significant
relation between aeration and erythromycin and tetracycline
removal. Similar results were reported by Iranzo et al. [108] who
found a 50 % removal for azithromycin but only 10 % removal for
citalopram. Fluoxetine was completely biodegraded in 15 days.
Authors identified 11 different strains of microorganisms that
degraded specific PhACs using them as carbon and nitrogen
sources. More recently, Zheng et al. [109] have described that
triclosan can be successfully removed by aerobic composting, with
slightly higher degradation related to an increase in aeration. In
addition, composting promotes microbial activity and increases
the relative abundance of microorganisms related to triclosan
degradation. Lastly, photodegradation has been found to have a
low impact on PhAC removal [110].
Over the last few years, authors have investigated the potential
use of emerging technologies such as hydrothermal carbonization,
biodrying, and hydrothermal liquefactionprior to the application of
sewage sludge to agricultural land and they have also tried to
improve sludge disposal. Eyser et al. [111] investigated the removal
of twelve PhACs in sewage sludge by hydrothermal carbonization
and found removal rates between 39 % for metoprolol and 97 % for
carbamazepine. In contrast phenazone concentration increased,
which could indicate that additional metabolites present in the
native sewage sludge might degrade to phenazone during the
treatment. Pilnacek et al. [112] highlighted the pretreatment with
biodrying, which uses the heat produced in the thermophilic phase
of composting to produce a biowaste-based product, for antibiotic
biodegradation. Silva Thomsen et al. [113] showed that hydrother-
mal liquefaction is a suitable technology for sewage sludge
treatment and for the the removal of 9 out of 30 PhACs and 5
out of 7 biocides investigated (over 98 % removal). Citalopram was
found to be moderately recalcitrant at 300 C (87 % removal) and it
was removed at temperatures >325 C (>99 % removal).
4. Occurrence of PhACs in soil after sludge application
Given the concentration levels of some PhACs found in treated
sludge, sludge disposal cannot be neglected, in particular when
applied to soil. Information on PhAC occurrence in soils amended
with digested or composted sludge is scarce (see Table 2) [25,114–
126]. The groups of PhACs detected at higher concentrations were
antimicrobials (triclosan and triclocarban) at 12003000 ng/g dm
and antibiotics (fluoroquinolones) at 50550 ng/g dm. Other
antibiotics frequently detected include oxytetracycline (100.9 ng/
g), tetracycline (63.8 ng/g), and sulfamethoxazole (47.9 ng/g)
[68,127]. Ibuprofen, diphenhydramine, diclofenac, fluoxetine,
fluoxetine, gemfibrozil, miconazole and azithromycin, have been
deteted at lower concentrations (660 ng/g dm) [128]. Fluoro-
quinolones, ibuprofen and naproxen have been detected at
different concentration ranges, which supports that a number of
factors such as sludge application frequency, soil conditions and
characteristics, precipitation and runoff may influence their
occurrence [27,129]. Based on the estimated annual load after
sludge application in the Slovak Republic, the total load of PhACs in
soils ranged between hundred grams to low hundreds of
kilograms. The highest input load was found for fexofenadine
(120 kg/year), verapamil (28 kg/year), citalopram (21 kg/year),
compound and soil [130]. Strongly sorbing PhACs tend to
accumulate in soil, whereas those highly mobile tend to leach to
groundwater and can be transported with groundwater flow,
drainage water, and surface runoff to surface waters [64]. In soil-
column experients, Lachasagne et al. [131] reported that the
leaching potential, and consequently the risk of groundwater
contamination, is mainly related to the sludge source and found
ibuprofen and diclofenac in the leachates of urban sludge amended
soil and salicylic acid and paracetamol only in the leachates of
hospital sludge-amended soil. Other PhACs including ciprofloxa-
cin, carbamazepine, ketoprofen, econazole, and atenolol were
found in soil but not in leachates. Similar results were also reported
by Shao et al. [132] and Chefetz et al. [133] who found that
diclofenac and carbamazepine exhibited low mobility in soils with
high organic matter levels [103]. Barron et al. [130] concluded that
some bound PhACs to topsoils migh leach (salbutamol, bezafibrate,
sulphamethazine, sulphamethoxazole or ketoprofen), while others
(trimethoprim, indomethacin, propranolol, metoprolol and carba-
mazepine) showed significant retention in soils and were therefore
more prevalent. Recently, Wang et al. [134] found different
behaviours of PhACs in soils amended with lime-stabilized sludge.
For example, erythromycin and naproxen increased their mobility
by 21.7 % and 33.8 %, respectively, carbamazepine, triclosan, and
fluoxetine reduced their mobility by 100 % after 63 days. The
authors also reported that pH effects on PhAC hydrophobicity and
speciation were highly correlated with the mobility of erythromy-
cin and fluoxetine, but these effects were slighly correlated with
the mobility of the rest of compounds.
Several authors have also assessed the dissipation or persist-
ance of PhACs with time. Walters et al. [116] used an outdoor
mesocosms experiment with sludge-amended soil and found no
noticiable loss of triclocarban, diphenhydramine, and fluoxetine
over the three-year monitoring period. In contrast norfloxacin,
azithromycin, and ciprofloxacin exhibited moderately high half-
lives (t1/2) (from 990 to 3466 days). Triclosan showed lower
persistence (t1/2 182–193 days), which is consistent with other
studies reporting that triclosan concentration decreased up to 80 %
after one year of sludge application [128,129]. Golet et al. [115]
found ciprofloxacin and norfloxacin at concentrations between
270300 ng/g dm and between 290400 ng/g dm in topsoil after
21 and 8 months of sludge application, respectively. Butler et al.
[129] reported that triclosan concentration in soil slightly
decreased during the first eight months after sludge application
to three different soil types. One year after the application, the
reduction was about 80 %. They explain that the reduction is related
to triclosan biodegradation to methyl triclosan, which was found at
0.4 mg/kg. Clotrimazole desorption from sludge-amended soil was
negligible, whereas fluconazole desorption was rapid. Clotrimazole
was more persistent than fluconazole in dry soil, whereas the
contrary occurred in wet soil [135].
Other studies have also explored the relations between
compound properties, soil characteristics, and their interactions.
Srinivasan et al. [136] observed that sulfamethoxazole sorption to
six dairy farm soils was positively related to TOC. However, higher
TOC % was correlated with higher cation exchange capacity and
specific surface [8]. Similarly, correlation studies have shown that
t1/2 of carbamazepine and triclosan was positively related to TOC,
while t1/2 of the two PhACs was negatively related to pH. Positive
correlations between sorption coefficients and TOC have been also
observed for trimethoprim and carbamazepine [137]. Similarly,telmisartan (16 kg/year), and diclofenac (12 kg/year). The metab-
olites of these compounds also contributed to the total load in soil
(9.8 %) [11].
PhAC behaviour in soil is a complex process that depends on
several factors affecting mass transfer such as the nature of the
aqueous solution and the physicochemical properties of both the9
Leal et al. [138] investigated the sorption of FQs and sulphona-
mides in amended soils and found that the most important factors
affecting the sorption were soil texture and cation exchange
capacity. Kodešová et al. [137] explored the effects of different soil
properties on PhAC sorption/desorption. Sorption of ionizable
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ound for clarithromycin, clindamycin, atenolol, and metoprolol.
ccording with their results, clarithromycin exhibited the highest
orption followed by trimethoprim, metoprolol, atenolol and
lindamycin. While carbamazepine and sulfamethoxazole exhib-
ted the lowest sorption and therefore higher mobility in soils,
hich may result in contamination of groundwater and accumu-
ation in plants. Other authors have highlighted that the dissolved
rganic matter (DOM) increases the apparent solubility of the
olute, therefore enhancing its mobility [103,133], but DOM can
lso reduce the mobility due to cumulative sorption and co-
orption to the soil’s solid phase. Le Guet et al. [139] have also
eported on these different effects of DOM on PhAC sorption
apacity (increase or decrease).
. Ecotoxicological effects and risks in sludge-amendeded soils
The risk quotient (RQ), ratio between measured (MEC) or
redicted environmental concentrations (PEC) with predicted no-
ffect concentrations (PNEC), is the most common approach to
dentify high- or low-risk ecotoxicological situations associated
with the presence of PhACs in the terrestrial environment,
especially in soil [140]. PNECs are usually calculated using the
lowest acute (lethal concentration (LC) or effect concentration
(EC)) and chronic toxicity data (no observed effect concentration
(NOEC)) in model organisms (fish, Daphnia magna and algae) and
dividing them by an assessment factor, between 1000 and 10,
respectively, to consider the worst-case scenario [25–27,141].
Because of the lack of acute toxicity data for some terrestrial
organisms such as earthworms, plants and soil microorganisms,
few studies use the PNEC values in soil to estimate the risk
[117,118]. Instead, an equilibrium partition approach through the
distribution or partition coefficients (Kd) is usually used to obtain
PNECsoil from PNECwater [25–27,142]. Table 3 shows the ecotoxico-
logical data and Kd values reported in the literature together with
the calculated PNECsoil [15,20,27,28,30,68,130,143–166]. It should
be noted that the toxicity data selected correspond to the most
sensitive species among those most commonly used in toxicity
studies. It also reveals the lack of data, for both ecotoxicological
and Kd data, available for metabolites.
The criteria usually applied to evaluate the risk using the RQ
model are those proposed by Hernando et al. [167] who classifies
able 3
cooxicological data and predicted no-effect concentration (PNEC) of measured PhACs in digested and dehydrated sludge or compost.
Pharmaceutical compound Ecotoxicological study Reference PNECwater (ug/L) Kd (L/kg) PNECsoil (ng/g dm)
Species Test Ecotoxicity (mg/L)
Ciprofloxacin M. aeruginosa (cianobacteria) EC50 0.005 [143] 0.005 427 2.135
17a-Ethinylestradiol S. purpuratus (invertebrate) EC50 0.03 [144] 0.03 3.35 0.1005
Triclosan fish chronic toxicity 0.005 [145] 0.05 127 6.35
Triclocarban fish chronic toxicity 0.00116 [145] 0.058 438 25.404
17ß-Estradiol S. purpuratus (invertebrate) EC50 0.01 [146] 0.01 3.3 0.033
Sulfametoxazole P. subcapitata (algae) EC50 (96 h) 0.15 [146] 0.15 8 1.2
Sertraline D. magna (crustacean) EC50 (21 d) 0.066 [147] 0.066 23.95* 1.5807
Tylosin M. aeruginosa S. (algae) EC50 0.034 [147] 0.034 128 4.352
Carbamazepine H. attenuate (invertebrate) EC50 (96 h) 3.76 [148] 3.76 13 48.88
Diclofenac V. pezeri (bacteria) EC50 (5 min) 3.8 [149] 3.8 9 34.2
Estrone T. battagliai (invertebrate) LC50 (10 d) 0.1 [150] 0.1 12.3 1.23
Fluoxetine P. subcapitata (algae) EC50 (120 h) 0.024 [147] 0.024 134 3.216
Atenolol D. rerio (fish) LC50 (96 h) 2.5 [151] 2.5 15 37.5
Ofloxacin S. leopolensis (algae) EC10 (7 d) 0.206 [152] 0.206 1192 245.552
Oxytetracycline M. Aeruginosa (algae) EC50 (72 h) 0.207 [147] 0.207 1030 213.21
Ketoprofen V. fischeri (bacteria) EC50 (15 min) 15.6 [153] 15.6 9 140.4
Ibuprofen H. attenuata (cnidarian) EC50 (96 h) 1.65 [148] 1.65 28.2 46.53
Caffeine S. Proboscideus (crustacean) LC50 (24 h) 0.409 [154] 0.409 25.12 10.27408
Erythromycin P. subcapitata (algae) EC50 0.06 [155] 0.06 68 4.08
Tetracycline M. aeruginosa (algae) EC50 0.09 [147] 0.09 1620 145.8
Claritromicin A. flos-aquae (cianobacteria) EC50 0.0056 [156] 0.0056 1200* 6.72
Propranolol D. subspicatus (algae) EC50 (48 h) 0.7 [157] 0.7 58 40.6
Estriol S. purpuratus (invertebrate) EC50 1.52 [144] 1.52 63* 95.76
Naproxen H. attenuata (cnidarian) EC50 (96 h) 2.62 [148] 2.62 11 28.82
Simvastatin N. spinipes (copepod) LC50 (96 h) 0.81 [147] 0.81 85 68.85
Sulfamethazine D. magna (crustacean) EC50 (21 d) 4.25 [147] 4.25 9 38.25
Trimetoprim V. pezeri (bacteria) EC50 (30 min) 0.28 [158] 0.28 26 7.28
Metoprolol D. subspicatus (algae) EC50 7.3 [147] 7.3 20 146
Gemfibrozil H. attenuata (cnidarian) EC50 (96 h) 1.18 [148] 1.18 54.8* 64.664
Paracetamol D. magna (crustacean) EC50 (48 h) 9.2 [154] 9.2 32 294.4
Sulfapyridine H. attenuata (cnidarian) EC50 (96 h) 21.61 [147] 21.61 8 172.88
Valsartan Algae – 3.94 [159] 3.94 92.75* 365.435
Clofibric acid L. minor (duckweed) EC50 (7 d) 12.5 [147] 12.5 9 112.5
Metformin D. subspicatus (algae) LC50 (4 d) 320 [160] 320 41.96* 13427.2
Bezafibrate Fish EC50 6 [161] 6 14 84
Salycilic acid V. fischeri (bacteria) EC50 (30 min) 90 [147] 90 82 7380
Sulfathiazole D. magna (crustacean) EC50 (96 h) 85.4 [147] 85.4 4.9 418.46
Irbesartan D. magna (crustacean) LC50 (48 h) 0.29 [162] 0.29 940* 272.6
Codeine D. magna (crustacean) EC50 16 [160] 16 15 240
Norfloxacin Algae EC 15 [163] 15 5791 86,86550
Azitromicin Algae EC50 (96 h) 19 [164] 19 2156* 40,964
Telmisartan D. magna (crustacean) LC50 (48 h) 7.813 [162] 7.813 5787* 45213.831
Lidocaine B. rerio (fish) LC50 (4 d) 106 [160] 106 52.79* 5595.74
Loratadine L. macrochirus (fish) LC50 (4 d) 0.4 [160] 0.4 31,425* 12,570
Fluconazole O. Latipes LC50 (4 d) 100 [147] 100 21.57* 2157
d data in soil taken from [20,27,68,130,165]; *: Kd data in sludge taken from [28,30,166].
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1) and high risk (RQs > 1). An environmental risk assessment in soil
amended with digested and dehydrated or composted sludge was
conducted using the PhAC concentrations gathered from our
literature review. PECsoil values were stimated one year after one
sludge-dose application to agricultural soil using the equation 1
provided by the European Commission Technical Guidance
Document on Risk Assessment [25]:
PECsoil = Csludge x APPLsludge/DEPTHsoil x RHOsoil (1)
where Csludge is the contaminant concentration in digested or
composted sludge; APPLsludge is the dry-sludge application rate
(0.5 kg/m2 year); DEPTHsoil is the mixing depth of soil (0.20 m) and
RHOsoil is the bulk density of wet soil (1700 kg/m3). The minimum
and maximum RQ values were estimated using the minimum and
maximum concentrations of PhACs in soils (Fig. 4). The most
critical compounds found in sludge-amended soil and that pose
the highest ecotoxicological risk were the fluoroquinolone
ciprofloxacin, the estrogens 17α-ethinylestradiol and 17β-estradiol
and the antomicrobials triclocarban and triclosan. The presence of
sulfamethozaxole, sertraline, tylosin, carbamazepine, diclofenac
and estrone was related to a medium but not insignificant risk, and
the metabolites salycilic acid and clofibric acid, two of the few for
which data are available, were associated to a low risk.
Using this same approach, Martín et al. [25,26] reported that
sulfamethoxazole, ibuprofen, gemfibrozil, 17β-estradiol and 17α-
ethinylestradiol were the most relevant compounds when assess-
ing the risks in digested and composted sewage sludge. However,
RQ dramatically decreased after sludge application to soils, with
17β-estradiol being the only PhACs exhibiting some potential toxic
effects. The authors selected toxicity data most commonly used in
toxicity studies and reported that to the most sensitive organisms,
such as H. attenuate or B. calyciflorus, the analysis of other PhACs
could have also resulted in ecotoxicological risk. In the study
conducted by Thomaidi et al. [118] and Gros et al. [168] triclosan
and norfloxacin represent a risk for soil life and crops. More
recently, Bastos et al. [103] reported RQ > 1 for trimethoprim,
ciprofloxacin and norfloxacin with acute and chronic effects in soils
amened with limed or digested sludge but RQ < 0.10 was found in
soils amended with organic wastes, which was a result of a
“dilution” effect suggesting low environmental risks. Lachassagne
et al. [131] reported that the estimated RQ for acute and chronic
effects of PhACs in soils amended with limed and digested sludge
was related with medium risks, mainly due to the presence of
sulfamethixazol.
Recent studies have also demonstrated that PhAC occurrence in
soils can result in changes in the microbial communities by
modifiying their ability to metabolize different carbon sources.
Pino-Otín et al. [169] reported that NSAIDs and antibiotics had the
lowest and highest risk of ecotoxicity, respectively, while lipid
regulators and β-blockers exhibited intermediate toxicity. The
most known health risk related to the presence of antibiotics in soil
and related environmental samples are associated to the risks that
promote the ocurrence and spread of antibiotic resistance in
pathogenic bacteria [68]. Several studies have reported on the
presence of genes related to antibiotic resistance in soil bacteria
[127,170]. Lastly, it has been reported that the presence of
antibiotics at subinhibitory concentrations in soil might act as
signaling molecules and can lead to the development of
spontaneous mutations in bacterial DNA, which is also associated
with different antibiotic resistance mechanisms [171,172].
6. Conclusions
The detection of PhACs at concentration from mg/kg to mg/kg
dm in sludge matrices is an indication that more monitoring of
detected PhACs is required. Such monitoring should also be
extended to metabolite analysis. Thirty-five classes of therapeutic
groups, including 180 PhACs and 45 metabolites, have been
analyzed in sludge from different countries. The most studied
classes of PhACs include antibiotics, NSAIDs, antiepileptic and
antidepressant drugs. Regarding the spatial distribution, Europe
and Asia are the two continents with more published studies about
the occurrence and effects of PhACs on sewage sludge. Despite
advances in sludge stabilization, many compounds and their
metabolites are not removed by sludge treatment. It is difficult to
determine the specific conditions that will reduce PhAC accumu-
lation in sludge as there are many factors involved. Promising
results have been reported when using AnD in combination with
other treatments. Information regarding the stabilization of PhACs
in aerobic versus anaerobic conditions is scarce as well as
regarding the behaviour and characterization of their metabolic
pathways.
Amendment of agricultural soils with treated sludge may be an
optimal way of sludge disposal. When sludge is mixed with soils,
this causes a “dilution” of contaminants, which reduces their
concentrations. Hydrothermal carbonization, biodrying or hydro-
thermal liquefaction have been recently investigated as potential
technologies that can be used prior to sludge application to
agriculture land in order to reduce the load of PhACs. In any case,
the use of treated sludge as fertilizers should be done with caution
because of the potential ecotoxicological risks associated with its
use. Available literature suggests that this risk is medium-low for
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ritical compounds (RQ > 1). Nevertheless, improvements in
nvironmental risk assessment are highly recommended, particu-
arly the investigation into PNEC. Ecotoxicological data are mainly
btained from aquatic organisms, but the information regarding
he effect of PhACs on terrestrial organisms is scarce. These
ifferences are particularly evident for PhAC metabolites, with the
dded lack of Kd data from both soil and sludge matrices, which
onsequently complicates the environmental risk assessment for
ost metabolites.
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